Middle East News Center: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Center.

Press releases published on October 1, 2026

Oct. 1, 2026

ENVI Paje: Becomes the First Property in Zanzibar to Offer Regenerative Therapies

Indeterminate EIN Presswire

Oct. 1, 2026

Nayax Completes Acquisition of IPS Group

Indeterminate GlobeNewswire

Oct. 1, 2026

WareGo Equips 3PL Providers with Advanced 3PL WMS Technology to Drive Client Retention and Scale Operations

Indeterminate EIN Presswire

Oct. 1, 2026

KONE to enable one of the world's longest single elevator journeys at Dubai's Burj Azizi

Indeterminate EIN Presswire

Oct. 1, 2026

إكس أس دوت كوم" تفوز بجائزة "الريادة العالمية في وساطة الأصول المتعددة" في معرض قطر المالي

Indeterminate EIN Presswire

Oct. 1, 2026

VIVOS Group Expands Global Presence with Launch of Dubai Corporate Services Office

Indeterminate EIN Presswire

Oct. 1, 2026

DTS Solution Reinforces Its Presence Among Kuwait’s Leading Cybersecurity Companies at CYSEC Kuwait 2026

Indeterminate EIN Presswire

Oct. 1, 2026

Greenland Mines Identifies Critical Minerals Additions Including Gallium and Vanadium as Landmark 2026 Skaergaard PGM Program Concludes

Indeterminate GlobeNewswire

Oct. 1, 2026

Nomad Universe Launches Official Travel Packages for Men's Rugby World Cup Australia 2027

Indeterminate EIN Presswire

Oct. 1, 2026

Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients

Indeterminate GlobeNewswire

Oct. 1, 2026

BOS Robotics Division Receives $380,000 Follow-On Order from a Leading Israeli Defense Customer

Indeterminate GlobeNewswire

Oct. 1, 2026

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

Indeterminate GlobeNewswire

Oct. 1, 2026

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

Indeterminate GlobeNewswire

Oct. 1, 2026

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Oct. 1, 2026

Qodo 3.0 Brings Enterprise-Grade Quality Control to Agentic Software Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Indeterminate GlobeNewswire

Oct. 1, 2026

PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities

Indeterminate GlobeNewswire

Oct. 1, 2026

QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader

Indeterminate GlobeNewswire

Oct. 1, 2026

RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP™ Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer

Indeterminate GlobeNewswire

Oct. 1, 2026

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

Indeterminate GlobeNewswire